Medpace Holdings Inc (MEDP) Stock Price, Quote & News

Company Profile

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management,...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 513 579 9911

Fax: 513 579 0444

Website: www.medpace.com

Address:

5375 Medpace Way, Cincinnati, United States

ripster47 Jun. 29 at 3:20 PM

$MEDP 🚨 This stock is at 537 now since idea provided at sub 400! Step by Step free idea provided at @TenetCharts #FF Will cover this swing setup in recaps! Big win for our bio portfolio tenetresearch.ai Hold your Winner if you want to grow portfolio

0 · Reply

ripster47 Jun. 25 at 8:10 PM

$MEDP 💰 Now hitting 530 from 386/400 Gap Fill Swing Strategy that @ripster47 teaches is one of best Swing Setups We do no do hindsight, we show real trades in action. See before/after Follow us for more chart setups before the move https://x.com/TenetCharts

0 · Reply

ripster47 Jun. 25 at 1:53 PM

$MEDP Biotech Swing Gave over 120$/share profit for us since idea shared FULL Gap fill See before/after Follow for more sure money making ideas before the move Special Thanks to @ripster47 Biotech Portfolio at https://x.com/TenetCharts

0 · Reply

ripster47 Jun. 24 at 6:29 PM

🚨 Our Biotech Porfolio hitting new highs today as Rotation into Biotechs $XBI $CELC $MEDP big winners for us Thanks to @Pharmdca $MEDP also big conviction by @PharmDabbler All ideas shared here before move Also Live Portfolio adds for tenetresearch.ai members

0 · Reply

BillionerOfKing Jun. 23 at 4:32 AM

$MEDP Current Stock Price: $455.70 Contracts to trade: $460.0 MEDP Jul 17 2026 Call Entry: $12.90 Exit: $16.53 ROI: 28% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

NVDAMillionaire May. 14 at 11:06 AM

$MEDP Great piece that accurately captures MEDP's current position. So if you want to refresh your understanding of MEDP or learn about MEDP for the first time, this is essential reading. https://everyticker.com/quote/MEDP/analysis/medpace-s-cancellation-crisis-meets-glp-1-gold-rush-a-high-stakes-test-of-cro-resilience-nasdaq-medp

0 · Reply

CapitalMonk May. 12 at 2:04 AM

$MEDP Price: $417.29 (-1.58%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.24% RSI: 25.8 | Momentum: Strong Downside Volume: -21.1% vs avg Volatility: 5.51% Support: $373.00 | Resistance: $530.97 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25

0 · Reply

ripster47 May. 6 at 12:54 PM

$MEDP Update Now breaking out into the gap fill Very Profitable Swing Trade since idea Idea working nicely so far Next Target 435s Top Position at @tenet_research See before after

0 · Reply

ripster47 May. 1 at 3:37 PM

$MEDP 🚨 This setup working nicely since the idea Now 1 HR MTF Flag for push into the gap on this swing name @Pharmdca @PharmDabbler @ripster47 See original trade idea in tweets below Profitable Biotech name https://x.com/TenetCharts

0 · Reply

BillionerOfKing May. 1 at 3:18 PM

$MEDP Current Stock Price: $417.36 Contracts to trade: $420.0 MEDP May 15 2026 Call Entry: $8.20 Exit: $10.78 ROI: 32% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026

May 18, 2026, 6:07 AM EDT - 6 weeks ago

MEDP Fraud Notice: Medpace Sued for Securities Fraud after 16% Stock Drop -- Investors Reminded to Contact BFA Law by June 8 Case Deadline

May 13, 2026, 6:18 AM EDT - 7 weeks ago

Medpace Lawsuit Reminder: Investors with Losses after Company Discloses Cancellation Rates are Urged to Contact BFA Law before June 8 Deadline - NASDAQ:MEDP

May 7, 2026, 6:13 AM EDT - 7 weeks ago

MEDP Fraud News: Medpace Sued for Securities Fraud Over Cancellation Rates and 16% Stock Drop – Contact BFA Law if You Lost Money

2026-04-24T12:40:41.000Z - 2 months ago

Medpace price target lowered to $400 from $460 at BMO Capital

2026-04-24T11:51:29.000Z - 2 months ago

Medpace price target lowered to $484 from $522 at RBC Capital

2026-04-24T10:36:05.000Z - 2 months ago

Medpace price target lowered to $477 from $565 at Baird

2026-04-24T09:35:33.000Z - 2 months ago

Medpace price target lowered to $450 from $500 at Barclays

2026-04-23T16:05:46.000Z - 2 months ago

Medpace falls -22.4%

2026-04-23T14:06:12.000Z - 2 months ago

Medpace falls -24.5%

Apr 23, 2026, 9:00 AM EDT - 2 months ago

Medpace Holdings Earnings Call Transcript: Q1 2026

Apr 23, 2026, 9:00 AM EDT - 2 months ago

Medpace Holdings Earnings release: Q1 2026

Apr 23, 2026, 9:00 AM EDT - 2 months ago

Medpace Holdings Quarterly report: Q1 2026

Apr 22, 2026, 4:15 PM EDT - 2 months ago

Medpace Holdings, Inc. Reports First Quarter 2026 Results

Apr 1, 2026, 9:00 AM EDT - 3 months ago

Medpace Holdings, Inc. Investigated by the Portnoy Law Firm

Apr 1, 2026, 8:00 AM EDT - 3 months ago

Medpace Holdings Proxy statement: Proxy filing

Apr 1, 2026, 8:00 AM EDT - 3 months ago

Medpace Holdings Proxy statement: Proxy filing

Mar 24, 2026, 4:05 PM EDT - 3 months ago

Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026

Mar 16, 2026, 8:00 AM EDT - 3 months ago

Medpace Holdings Proxy statement: Proxy Filing

2026-03-06T11:25:12.000Z - 4 months ago

Medpace upgraded to Equal Weight from Underweight at Barclays

2026-03-06T11:10:40.000Z - 4 months ago

Medpace upgraded to Equal Weight from Underweight at Barclays

2026-03-03T00:40:10.000Z - 4 months ago

Medpace initiated with an Outperform at RBC Capital

Feb 18, 2026, 9:00 AM EST - 4 months ago

Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility

2026-02-18T10:55:16.000Z - 4 months ago

Medpace upgraded to Hold from Sell at TD Cowen

2026-02-13T11:39:22.000Z - 4 months ago

Medpace upgraded to Buy from Hold at Jefferies

2026-02-11T13:45:36.000Z - 5 months ago

Medpace price target lowered to $539 from $555 at Truist

2026-02-11T12:15:42.000Z - 5 months ago

Medpace price target lowered to $460 from $600 at BMO Capital

Feb 11, 2026, 2:00 AM EST - 5 months ago

Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial

2026-02-10T21:00:15.000Z - 5 months ago

Baird upgrades Medpace to Outperform on earnings selloff

2026-02-10T18:50:14.000Z - 5 months ago

Medpace upgraded to Outperform from Neutral at Baird

Feb 10, 2026, 9:00 AM EST - 5 months ago

Medpace Holdings Earnings Call Transcript: Q4 2025

Feb 10, 2026, 9:00 AM EST - 5 months ago

Medpace Holdings Annual report: Q4 2025

Feb 10, 2026, 9:00 AM EST - 5 months ago

Medpace Holdings Earnings release: Q4 2025

Feb 10, 2026, 9:00 AM EST - 5 months ago

Medpace Holdings Slides: Q4 2025

Feb 9, 2026, 4:15 PM EST - 5 months ago

Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results

Jan 5, 2026, 4:05 PM EST - 6 months ago

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026

Oct 23, 2025, 11:15 AM EDT - 8 months ago

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back

Oct 23, 2025, 9:00 AM EDT - 8 months ago

Medpace Holdings Earnings Call Transcript: Q3 2025

Oct 23, 2025, 9:00 AM EDT - 8 months ago

Medpace Holdings Quarterly report: Q3 2025

Oct 23, 2025, 9:00 AM EDT - 8 months ago

Medpace Holdings Earnings release: Q3 2025

Oct 23, 2025, 9:00 AM EDT - 8 months ago

Medpace Holdings Slides: Q3 2025

Oct 22, 2025, 4:15 PM EDT - 8 months ago

Medpace Holdings, Inc. Reports Third Quarter 2025 Results

Sep 23, 2025, 4:05 PM EDT - 10 months ago

Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025

Jul 22, 2025, 9:00 AM EDT - 1 year ago

Medpace Holdings Earnings Call Transcript: Q2 2025

Jul 22, 2025, 9:00 AM EDT - 1 year ago

Medpace Holdings Quarterly report: Q2 2025

Jul 22, 2025, 9:00 AM EDT - 1 year ago

Medpace Holdings Earnings release: Q2 2025

Jul 22, 2025, 9:00 AM EDT - 1 year ago

Medpace Holdings Slides: Q2 2025

Jul 22, 2025, 7:36 AM EDT - 1 year ago

This Clinical Trials Stock Just Soared 40%. What Caused It to Pop.

Jul 21, 2025, 4:15 PM EDT - 1 year ago

Medpace Holdings, Inc. Reports Second Quarter 2025 Results

Jun 23, 2025, 4:05 PM EDT - 1 year ago

Medpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

Medpace Holdings Slides: Investor Presentation

Apr 22, 2025, 9:00 AM EDT - 1 year ago

Medpace Holdings Earnings Call Transcript: Q1 2025

Apr 22, 2025, 9:00 AM EDT - 1 year ago

Medpace Holdings Quarterly report: Q1 2025

Apr 22, 2025, 9:00 AM EDT - 1 year ago

Medpace Holdings Earnings release: Q1 2025

Apr 22, 2025, 9:00 AM EDT - 1 year ago

Medpace Holdings Slides: Q1 2025

Apr 21, 2025, 4:15 PM EDT - 1 year ago

Medpace Holdings, Inc. Reports First Quarter 2025 Results

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Medpace Holdings Proxy statement: Proxy Filing

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Medpace Holdings Proxy statement: Proxy Filing

Mar 18, 2025, 4:05 PM EDT - 1 year ago

Medpace Holdings, Inc. to Report First Quarter 2025 Financial Results on April 21, 2025

Feb 11, 2025, 9:00 AM EST - 1 year ago

Medpace Holdings Earnings Call Transcript: Q4 2024

Feb 11, 2025, 9:00 AM EST - 1 year ago

Medpace Holdings Annual report: Q4 2024

Feb 11, 2025, 9:00 AM EST - 1 year ago

Medpace Holdings Earnings release: Q4 2024

Feb 11, 2025, 9:00 AM EST - 1 year ago

Medpace Holdings Slides: Q4 2024

Feb 10, 2025, 4:15 PM EST - 1 year ago

Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Results

Jan 2, 2025, 4:05 PM EST - 1 year ago

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 10, 2025

ripster47 Jun. 29 at 3:20 PM

0 · Reply

ripster47 Jun. 25 at 8:10 PM

0 · Reply

ripster47 Jun. 25 at 1:53 PM

0 · Reply

ripster47 Jun. 24 at 6:29 PM

0 · Reply

BillionerOfKing Jun. 23 at 4:32 AM

0 · Reply

NVDAMillionaire May. 14 at 11:06 AM

0 · Reply

CapitalMonk May. 12 at 2:04 AM

0 · Reply

ripster47 May. 6 at 12:54 PM

$MEDP Update Now breaking out into the gap fill Very Profitable Swing Trade since idea Idea working nicely so far Next Target 435s Top Position at @tenet_research See before after

0 · Reply

ripster47 May. 1 at 3:37 PM

0 · Reply

BillionerOfKing May. 1 at 3:18 PM

0 · Reply

ripster47 Apr. 30 at 9:20 PM

$XBI ❤️ Finally getting some love $XBI $CRVS $CTMX $TMDX $MEDP , 1 DAY of green after so much pain last few sessions Just need Yields to stay down and back up we go A Peace deal should help @Pharmdca @PharmDabbler @semodough @LTbioinvestor

0 · Reply

ripster47 Apr. 28 at 4:15 PM

$MEDP Low Float - Perfect Swing Long Setup! Watch the video to learn how to trade this repeatable pattern 🎯 https://x.com/i/status/2049142975859712332

0 · Reply

PenkeInvesting Apr. 25 at 5:47 AM

Fundamental analysis of $MEDP (Medpace Holdings, Inc.) based on financial data and reported results. #MEDP #Medpace

0 · Reply

maple_leaf1635377 Apr. 23 at 6:30 PM

$MEDP easy swing.

0 · Reply

WAJeff Apr. 23 at 5:48 PM

$MEDP $355 level? What are we thinking? I’d laugh if it happened but 14 day rsi at 20% is $309.40 and July 18, 2025 gap is right in the vicinity.

1 · Reply

ripster47 Apr. 23 at 4:02 PM

$MEDP 💡 New Gap Fill Setup , 400 holds should get pushing higher back towards 500 Did same bounce after last earnings Medpace beat Q1. EPS $4.28 vs $3.86–$3.94 expected big beat. Revenue $706M vs $692–696M. Full-year guide raised to $2.78B–$2.89B, 8.9–12.8% growth. https://x.com/TenetCharts

0 · Reply

IjustTradeiT Apr. 23 at 2:43 PM

$MEDP 200 coming

1 · Reply

FlashMcGash Apr. 23 at 2:01 PM

$MEDP this is nuts! In under $400 ...hands over fists

0 · Reply

Jagomendy Apr. 23 at 1:42 PM

$MEDP cancellations an issue but have not impacted revenues to date. No expectation of any negative impact in 2026.

0 · Reply

Jagomendy Apr. 23 at 1:40 PM

$MEDP still hiring. 2026 Revenues and Income guidance intact. Steal at this level.

0 · Reply

Messerschmittbf109 Apr. 23 at 1:35 PM

$MEDP mmmmh

0 · Reply

Warren1989 Apr. 23 at 1:24 PM

$MEDP this conference call is a disaster. The medpace team needs to get their act together. They are not polished and fumbling for answers. I can see why this is crashing.

0 · Reply

Market Cap	15.27B
Revenue (ttm)	2.53B
Net Income (ttm)	451.12M
EPS (ttm)	N/A
PE Ratio	33.13
Forward PE	30.93
Profit Margin	17.83%
Debt to Equity Ratio	0.00

Volume	335,500
Avg Vol	380,308
Day's Range	N/A - N/A
Shares Out	28.56M
Stochastic %K	89%
Beta	1.18
Analysts	Sell
Price Target	$453.91